Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third-party MSCs for Refractory Chronic GVHD
NCT01765660Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2013
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in chronic graft-versus-host disease (cGVHD), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01765660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765660.